文献速递药物不良反应与药物警戒

健康补充剂中的维生素B6与神经病变:自发报告病例系列评估

Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases.
PubMed 文献 · Drug Saf · 2018-01-01

荷兰药物警戒中心Lareb分析了90份含维生素B6产品引起周围神经病变的自发报告,产品每片含量1.4至100 mg,36例有血清维生素B6水平(均值907 nmol/l)。病例系列因果评估显示维生素B6补充剂可能导致神经病变,尤其在高剂量和长期使用时,但低于50 mg/日的剂量也不能排除。

要点

  • 维生素B6补充剂与周围神经病变存在合理因果关联。
  • 高剂量和长期使用风险更明显,但低于50 mg/日也不能排除。
  • 产品维生素B6含量差异大(1.4-100 mg/片),需关注实际暴露剂量。

核心结论

  • 病例系列因果评估表明维生素B6补充剂可能导致神经病变,尤其在高剂量和长期使用时,但低于50 mg/日的剂量也不能排除。

研究设计与样本

  • 对荷兰药物警戒中心Lareb收到的90份含维生素B6产品且至少包含一个周围神经病变不良事件报告进行描述性病例系列评估。
  • 采用Naranjo概率量表评估个体病例因果关系,采用Bradford Hill标准评估整个病例系列因果关系。

主要发现

  • 共90份报告含至少一个MedDRA标准化查询(SMQ,广泛)「周围神经病变」的不良反应。
  • 产品中维生素B6含量为每片1.4至100 mg。
  • 36例报告有血清维生素B6水平,范围为88-4338 nmol/l,平均值为907 nmol/l。
  • 未发现剂量与血清维生素B6水平之间存在统计学相关性。

临床怎么用

  • 临床应关注含维生素B6补充剂引起的周围神经病变,尤其在高剂量和长期使用时。
  • 即使日剂量低于50 mg,也应警惕神经病变风险,详细询问补充剂使用史。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In the literature, vitamin B6 has been linked to the development of polyneuropathy. Most often, these complaints were seen when taking high doses of vitamin B6 for a long time. Evidence as to whether a lower dosage range of vitamin B6 (< 50 mg/day) can also induce neuropathy is scarce. OBJECTIVE: We aim to comprehensively describe the cases of neuropathy associated with vitamin B6 received by the Netherlands Pharmacovigilance Centre Lareb and to assess the case series concerning the use of vitamin B6 and neuropathic complaints. METHODS: We describe the number and nature of the reported cases, including suspect product, dosage, duration of use, and vitamin B6 serum levels. In addition, we describe the causality for the individual cases (Naranjo Probability Scale) and for the entire case series (Bradford Hill criteria). RESULTS: In total, 90 reports on products containing vitamin B6 included at least one adverse drug reaction in the standardized Medical Dictionary for Regulatory Activities (MedDRA®) query (SMQ; broad) 'peripheral neuropathy'. The amount of vitamin B6 in the products varied between 1.4 and 100 mg per tablet. The serum vitamin B6 level was known in 36 cases (88-4338 nmol/l), and the mean serum vitamin B6 level was 907 nmol/l. However, no statistical correlation between dosage and vitamin B6 blood levels was found. DISCUSSION AND CONCLUSION: Causality assessment of the case series of 90 reports to Lareb shows it is plausible for the vitamin B6 supplements to have caused complaints such as neuropathies. This is especially the case with higher dosages and prolonged use, but dosages < 50 mg/day also cannot be excluded.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. van Hunsel F, van de Koppel S, van Puijenbroek E, et al. Vitamin B6 in Health Supplements and Neuropathy: Case Series Assessment of Spontaneously Reported Cases. Drug Saf. 2018. PMID: 29737502. doi:10.1007/s40264-018-0664-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。